26 | 06 | 2025

The Deal That Didn’t Break Them: How One Private Equity Firm Avoided a Multi-Million Dollar Mistake with aiMDC

When the Fine Print Spoke Loudest: AI-Powered Insight in High-Stakes Diligence | Case Study

A leading mid-market Private Equity firm was moving fast on what appeared to be a lucrative acquisition—on paper, the target company showed strong EBITDA, market share growth, and promising projections. However, time was tight. The firm had received over 500 pages across multiple Confidential Information Memorandums (CIMs) and related documents—financials, operational breakdowns, customer data summaries, and technical appendices. The pressure was on to close fast.

As the internal team sifted through the documents, they struggled to pinpoint deeper issues hidden beneath polished executive summaries. Manually reviewing such dense, jargon-heavy materials across multiple target companies risked missing critical red flags buried deep in footnotes, assumptions, or disclaimers. That’s when they turned to aiMDC.

aiMDC was deployed to rapidly ingest and analyze the entire dataset—over 10 CIMs in parallel, each hundreds of pages long. With zero hallucination output, pinpoint highlighting, and advanced financial text comprehension, the AI flagged multiple inconsistent data points and risk indicators the human team had overlooked. What looked like a high-return opportunity was in fact a liability-laden operation with overstated revenue projections, buried litigation risks, and unfavorable contract clauses—all revealed with full source traceability.

Client

A U.S.-based mid-market Private Equity firm managing $5B in assets with a focus on acquiring growth-stage technology and B2B service companies.

Environment

The client was evaluating a competitive bid for a tech acquisition involving multiple CIMs and supporting documents exceeding 5,000 pages total, with a 10-day window for diligence before a soft deadline.

Objective

Identify hidden financial, legal, and operational risks across large volumes of documentation—faster and more accurately than traditional manual review methods.

What was done

aiMDC processed all CIMs and attachments in parallel, leveraging multi-document cross-referencing and zero hallucination analysis. The system flagged discrepancies in customer churn data, contradictory claims about debt coverage, and litigation notes buried in footnotes. These issues were highlighted with exact page references and plain-language explanations.

Achievement

By using aiMDC, the firm avoided a potentially catastrophic investment. The flagged discrepancies triggered a deeper investigation, confirming overstated revenue recognition, misrepresented customer retention, and legal liabilities that had been strategically downplayed in executive summaries. The AI’s traceable answers and highlighted evidence empowered the team to confidently walk away from the deal, saving an estimated $30M in projected loss. More importantly, they gained a new diligence standard: from now on, every deal review begins with aiMDC. This not only elevated their risk management but accelerated review cycles by 70%—turning a one-time rescue into a long-term strategic advantage.

What happens next…
Take control of your document challenges today. Connect with our experts, see aiMDC in action, and discover how precision AI can transform your workflow—saving you time, reducing risks, and boosting results. Ready to lead with confidence? Let’s get started now!

AI SaaS Across Domains: ITFinancial ServicesInsuranceUnderwriting ActuarialPharmaceuticalIndustrial ManufacturingEnergyLegalMedia and EntertainmentTourismRecruitmentAviationHealthcareTelecommunicationLaw FirmsFood and Beverage and Automotive.

OTHER CASE STUDIES

02 | 07 | 2025

The 500-Document Challenge: Winning Speed and Accuracy in Pharma Compliance

By using aiMDC, this biopharma company uncovered hidden compliance risks across hundreds of complex documents, fast-tracking their drug approval process and avoiding costly regulatory delays.
06 | 04 | 2025

Lost in Translation? How One Pharma Giant Averted Regulatory Delay with AI

Facing a tight regulatory deadline, a top pharma firm used aiMDC to translate and analyze complex trial data across languages—avoiding costly delays and reputational risk
04 | 02 | 2025

Racing the Clock: How AI Accelerated Due Diligence and Prevented a Costly Misstep

aiMDC enabled a Private Equity firm to complete due diligence on a multi-company deal in 3 days, surfacing hidden risks and preventing an $18M overvaluation
12 | 12 | 2024

Bridging the Gap: How AI Prevented a Compliance Crisis by Harmonising Global Pharma Policies

A pharma giant used AI to identify and fix inconsistent SOPs worldwide, avoiding $15M in fines and strengthening regulatory compliance